First Drug Approved for Tardive Dyskinesia (FREE)

By Amy Orciari Herman Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM The FDA has approved valbenazine (Ingrezza) capsules to treat adults with tardive dyskinesia. The vesicular monoamine …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news